» Articles » PMID: 40001981

Farnesol Improves Endoplasmic Reticulum Stress and Hepatic Metabolic Dysfunction Induced by Tunicamycin in Mice

Overview
Journal Biology (Basel)
Publisher MDPI
Specialty Biology
Date 2025 Feb 26
PMID 40001981
Authors
Affiliations
Soon will be listed here.
Abstract

Endoplasmic reticulum (ER) stress significantly affects liver metabolism, often leading to disorders such as hepatic steatosis. Tunicamycin (TM), a known ER stress inducer, is frequently used to model metabolic stress, but its specific effects on liver energy homeostasis remain unclear. This study investigates how farnesol (FOH), a natural compound with antioxidant and anti-inflammatory properties, counteracts TM-induced ER stress and its associated metabolic disruptions in the liver. Using both primary hepatocytes and a mouse model, this study demonstrates that TM treatment caused upregulation of ER stress markers, including ATF4, and disrupted genes related to lipid metabolism and gluconeogenesis. Co-treatment with FOH reduced these stress markers and restored the expression of metabolic genes. In vivo, FOH treatment alleviated oxidative stress, reduced lipid accumulation, and restored normal glycogen and lipid metabolism. Histological analysis further confirmed that FOH preserved liver architecture and minimized cellular damage. FOH also stabilized serum lipid profiles and modulated key metabolic biomarkers, suggesting its protective role against TM-induced liver injury. These findings suggest that FOH has therapeutic potential in mitigating ER stress-related metabolic dysfunctions, offering promising insights for the treatment of liver diseases linked to metabolic stress.

References
1.
Han X, Zhang X, Li H, Huang S, Zhang S, Wang F . Tunicamycin enhances the antitumor activity of trastuzumab on breast cancer in vitro and in vivo. Oncotarget. 2015; 6(36):38912-25. PMC: 4770746. DOI: 10.18632/oncotarget.5334. View

2.
Bae J, Jo A, Cho S, Lee Y, Kam T, You C . Farnesol prevents aging-related muscle weakness in mice through enhanced farnesylation of Parkin-interacting substrate. Sci Transl Med. 2023; 15(711):eabh3489. DOI: 10.1126/scitranslmed.abh3489. View

3.
Ding C, Wang Z, Dou X, Yang Q, Ning Y, Kao S . Farnesoid X receptor: From Structure to Function and Its Pharmacology in Liver Fibrosis. Aging Dis. 2023; 15(4):1508-1536. PMC: 11272191. DOI: 10.14336/AD.2023.0830. View

4.
Yuan S, She D, Jiang S, Deng N, Peng J, Ma L . Endoplasmic reticulum stress and therapeutic strategies in metabolic, neurodegenerative diseases and cancer. Mol Med. 2024; 30(1):40. PMC: 10956371. DOI: 10.1186/s10020-024-00808-9. View

5.
Youssefi M, Nikpay A, Hassanpour N, Mirzapour A, Tabari P, Pavela R . In Vitro Scolicidal Activity of the Sesquiterpenes Isofuranodiene, α-Bisabolol and Farnesol on Protoscoleces. Molecules. 2020; 25(16). PMC: 7464821. DOI: 10.3390/molecules25163593. View